Reassessment of the concept of a therapeutic range of anticonvulsant plasma levelsVAJDA, F. J. E; AICARDI, J.Developmental medicine and child neurology (Print). 1983, Vol 25, Num 5, pp 660-671, issn 0012-1622Article

Succinylcholine―tissue distribution and elimination from plasma in the dogNORDGREN, I; BALDWIN, K; FORNEY, R. JR et al.Biochemical pharmacology. 1984, Vol 33, Num 15, pp 2519-2521, issn 0006-2952Article

Induction of DNA repair synthesis in human urothelial cells by the N-hydroxy metabolites of carcinogenic arylamines = Induction de la synthèse de réparation du DNA dans les cellules urothéliales humaines par les métabolites N-hydroxy des arylamines carcinogènesCHING YUNG WANG; CHRISTENSEN, B; ZUKOWSKI, K et al.Journal of the National Cancer Institute. 1984, Vol 72, Num 4, pp 847-852, issn 0027-8874Article

Clinical relevance of thiothixene plasma levelsMAVROIDIS, M. L; KANTER, D. R; HIRSCHOWITZ, J et al.Journal of clinical psychopharmacology. 1984, Vol 4, Num 3, pp 155-157, issn 0271-0749Article

Haloperidol and cerebral metabolism in the conscious rat: relation to pharmacokineticsPIZZOLATO, G; SONCRANT, T. T; RAPOPORT, S. I et al.Journal of neurochemistry. 1984, Vol 43, Num 3, pp 724-732, issn 0022-3042Article

Platelet monoamine oxidase inhibition by deprenyl and tranylcypromine: implications for clinical useSIMPSON, G. M; FREDERICKSON, E; PALMER, R et al.Biological psychiatry (1969). 1985, Vol 20, Num 6, pp 684-687, issn 0006-3223Article

Doses of aminophylline given intravenously in casualty department and resulting serum theophylline concentrationsMUNRO, C. S; PROWSE, K.British medical journal (1857). 1984, Vol 289, Num 6441, pp 354-355, issn 0007-1447Article

Metabolism of aminoglutethimide in humans: quantification and clinical relevance of induced matabolismGOSS, P. E; JARMAN, M; GRIGGS, L. J et al.British journal of cancer. 1985, Vol 51, Num 2, pp 259-262, issn 0007-0920Article

Arzneimittel und Organismus. IV: Pro-drugs, ein Weg zur Arzneimitteloptimierung = Médicaments et organisme. IV: Promédicaments, une voie pour l'optimisation des médicaments = Drugs and organism. IV: Pro-drugs, a way to drug optimizationPFEIFER, S.Pharmazie. 1983, Vol 38, Num 10, pp 663-666, issn 0031-7144Article

Clinical pharmacology of propafenoneCONNOLLY, S. J; KATES, R. E; LEBSACK, C. S et al.Circulation (New York, N.Y.). 1983, Vol 68, Num 3, pp 589-596, issn 0009-7322Article

Dose-dependent metabolism, therapeutic effect, and toxicity of anticancer drugs in manPOWIS, G; GILLETT, J. R.Drug metabolism reviews (Softcover ed.). 1983, Vol 14, Num 6, pp 1145-1163, issn 0360-2532Article

Pharmacokinetics of heparin V: in vivo and in vitro factors affecting the relationship between concentration and anticoagulant effect of heparin in rat plasmaWHITFIELD, L. R; LEVY, G.Journal of pharmaceutical sciences. 1983, Vol 72, Num 10, pp 1141-1146, issn 0022-3549Article

Serum iron concentrations following administration of two different iron preparationsDANISI, M; GUERRESI, E; LANDUCCI, G et al.Journal of international medical research. 1987, Vol 15, Num 6, pp 374-378, issn 0300-0605Article

Species differences in the N-acetylation by liver cytosol of mutagenic heterocyclic aromatic amines in protein pyrolysates = Différences entre les espèces dans la N-acétylation par le cytosol hépatique des amines aromatiques hétérocycliques mutagènes dans des pyrolysats de protéinesSHINOHARA, A; YAMAZOE, Y; SAITO, K et al.Carcinogenesis (New York. Print). 1984, Vol 5, Num 5, pp 683-686, issn 0143-3334Article

Inactivation de l'isoniazide chez l'enfant = Isoniazid inactivation in childrenPAIRE, M; LAVARENNE, J; RODET, M. F et al.Thérapie (Paris). 1984, Vol 39, Num 6, pp 625-631, issn 0040-5957Article

Coupling between renal tubular secretion and effect of bumetanideODLIND, B; BEERMANN, B; LINDSTROM, B et al.Clinical pharmacology and therapeutics. 1983, Vol 34, Num 6, pp 805-809, issn 0009-9236Article

Determination of bioequivalence of psychotrophic drugs and concerns involving product interchangeBARONE, J. A; BYERLY, W. G.The Journal of clinical psychiatry. 1986, Vol 47, pp 28-32, issn 0160-6689, supplArticle

Les théophyllines retard indications et prescription: la théophyllinémie = Sustained theophylline: chemotherapy and theophyllinemiaPOISSON, A; BRUGEROLLES; ARNAUD, A et al.Lyon méditerranée médical. 1985, Vol 21, Num 1-2, pp 9627-9630, issn 0399-032X, 3 p.Article

Effects of nifedipine on esophageal motor function in humans: correlation with plasma nifedipine concentrationHONGO, M; TRAUBE, M; MCALLISTER, R. G. JR et al.Gastroenterology (New York, NY. 1943). 1984, Vol 86, Num 1, pp 8-12, issn 0016-5085Article

Plasma concentrations of unbound phenytoin in the management of epilepsyKILPATRICK, C. J; WANWIMOLRUK, S; WING, L. M. H et al.British journal of clinical pharmacology. 1984, Vol 17, Num 5, pp 539-546, issn 0306-5251Article

In consideration of active metabolitesPOYNOR, W. J.Journal of clinical pharmacology. 1987, Vol 27, Num 3, pp 167-168, issn 0091-2700Article

A common single binding site for many psychotropic drugs on human α₁-acid glycoprotein. Therapeutically relevant observation?MÜLLER, W. E.Pharmacopsychiatry. 1985, Vol 18, Num 4, pp 257-258, issn 0176-3679Article

Polyglutamation of methotrexate: is methotrexate a prodrug?CHABNER, B. A; ALLEGRA, C. J; CURT, G. A et al.The Journal of clinical investigation. 1985, Vol 76, Num 3, pp 907-912, issn 0021-9738Article

Toxicologie et pharmacologie moléculaires: métabolisme des médicaments. Prévision d'éventuels effets secondaires toxiques = Molecular toxicology and pharmacology: drug metabolism. Prospective toxical secondary effectsMANSUY, D.1985, 21 p.Report

Effects of the α-carboline, FG 7142, in the social interaction test of anxiety and the holeboard: correlations between behaviour and plasma concentrationsFILE, S. A; PELLOW, S; BRAESTRUP, C et al.Pharmacology, biochemistry and behavior. 1985, Vol 22, Num 6, pp 941-944, issn 0091-3057Article